Abstract
BLC-200013 is an erratum of BLC-190218. In the funding section on page 141 of BLC-190218, the authors have reported no sources of funding related to this article. However, this is incorrect and the funding details should be specified in the funding section with the following text: This work was supported in part by NCI/NIH grants CA143971 and CA075115 to D.T. The funding details in the erratum BLC-200013 contained the wrong grant number. As such, the updated funding section of this article is provided below. FUNDING This work was supported in part by NCI/NIH grants CA143971 and CA075115 to D.T.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 109 |
| Number of pages | 1 |
| Journal | Bladder Cancer |
| Volume | 7 |
| Issue number | 1 |
| DOIs |
|
| State | Published - 2021 |
ASJC Scopus subject areas
- Oncology
- Urology
Fingerprint
Dive into the research topics of 'Erratum: Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (Bladder Cancer (2020) 6: 4 (559-559) DOI: 10.3233/BLC-200013)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS